Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Esther, Molnar"'
Impact of deceased organ donor injection drug use on donor culture positivity and recipient outcomes
Autor:
Krista Moore, Ebbing Lautenbach, Emily A. Blumberg, Jennifer Han, Dong Heun Lee, Heather Clauss, Richard Hasz, Warren B. Bilker, Esther Molnar, Darcy Alimenti, Sharon West, Pam Tolomeo, Judith A. Anesi
Publikováno v:
Transpl Infect Dis
BACKGROUND: Due to the ongoing opioid epidemic in the United States, deceased organ donors increasingly have a history of injection drug use (IDU), raising concerns about infectious risks to solid organ transplant (SOT) recipients. We sought to deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29eb4f56b5a81fc4da05c8152491157b
https://europepmc.org/articles/PMC9780151/
https://europepmc.org/articles/PMC9780151/
Autor:
Heather Clauss, Darcy Alimenti, Ebbing Lautenbach, Dong Heun Lee, Esther Molnar, Warren B. Bilker, Jennifer H Han, Antonette Climaco, Sharon West, Emily A. Blumberg, Richard Hasz, Cdc Prevention Epicenters Program, Judith A Anesi, Pam Tolomeo
Publikováno v:
Am J Transplant
The extent to which donor multidrug-resistant organisms (MDROs) affect organ utilization remains unclear. We performed a retrospective cohort study at 4 transplant centers between 2015 and 2016 to evaluate this question. All deceased donors who donat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9717e4126481f9e1bf936431e464caff
https://doi.org/10.1111/ajt.15830
https://doi.org/10.1111/ajt.15830
Autor:
Antonette Climaco, Esther Molnar, Sharon West, Ebbing Lautenbach, Jennifer H. Han, Dong Heun Lee, Judith A Anesi, Warren B. Bilker, Richard Hasz, Heather Clauss, Darcy Alimenti, Emily A. Blumberg, Pam Tolomeo
Publikováno v:
American Journal of Transplantation. 19:2468-2478
Donor infection or colonization with a multidrug-resistant organism (MDRO) affects organ utilization and recipient antibiotic management. Approaches to identifying donors at risk of carrying MDROs are unknown. We sought to determine the risk factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3fe848fad1a39dd89835923ebb5bdc
https://doi.org/10.1111/ajt.15488
https://doi.org/10.1111/ajt.15488
Autor:
Emily A. Blumberg, Darcy Alimenti, Richard Hasz, Pam Tolomeo, Judith A Anesi, Heather Clauss, Antonette Climaco, Jennifer H Han, Esther Molnar, Dong Heun Lee, Sharon West, Ebbing Lautenbach, Warren B. Bilker
Publikováno v:
Clin Infect Dis
Antibiotic use in deceased organ donors has not been previously described. In a retrospective cohort of 440 donors, we found 427 (97%) received at least one antibiotic course, 312 (71%) received broad-spectrum antibiotics, and 61 (14%) received poten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e90940bf9c58de3c5d848e0bf6472baa
https://pubmed.ncbi.nlm.nih.gov/34015084
https://pubmed.ncbi.nlm.nih.gov/34015084
Autor:
Krista Moore, Ebbing Lautenbach, Emily Blumberg, Jennifer Han, Dong Heun Lee, Heather Clauss, Richard Hasz, Warren Bilker, Antonette Climaco, Esther Molnar, Darcy Alimenti, Sharon West, Pam C Tolomeo, Judith A Anesi
Publikováno v:
Open Forum Infectious Diseases
Background With the ongoing opioid epidemic in the US, there has been an increase in the proportion of deceased organ donors with a history of injection drug use (IDU), raising concern for additional infectious risks to transplantation.We sought to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86181625b2eeae8fa22eaf2069494236
http://europepmc.org/articles/PMC8644494
http://europepmc.org/articles/PMC8644494
Autor:
Esther Molnar, Kenneth Biason, Yi Guo, Deepali Dixit, Michael J. Satlin, Emily L. Heil, Abdulrahman Elabor, Kimberly C. Claeys, Erin K McCreary, Saira B. Chaudhry, Jon Hiles, Dorothy McCoy, Nidhi Saraiya, Jason C. Gallagher, Claudine El-Beyrouty, Madeline A King, Lynette Richards, Christopher M. Bland, Daohai Yu, Jin S Suh, Nikunj Vyas, Bruce M Jones, Xiaoning Lu, Nicole Harrington
Publikováno v:
Open Forum Infectious Diseases. 5
Background Multidrug-resistant Pseudomonas aeruginosa infections remain common in hospitals worldwide. We investigated the outcomes associated with the use of ceftolozane-tazobactam for the treatment of these infections. Methods Data were collected r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3731563f672f2cc1ffbbe4808180db38
https://doi.org/10.1093/ofid/ofy280
https://doi.org/10.1093/ofid/ofy280
Autor:
Jason C, Gallagher, Michael J, Satlin, Abdulrahman, Elabor, Nidhi, Saraiya, Erin K, McCreary, Esther, Molnar, Claudine, El-Beyrouty, Bruce M, Jones, Deepali, Dixit, Emily L, Heil, Kimberly C, Claeys, Jon, Hiles, Nikunj M, Vyas, Christopher M, Bland, Jin, Suh, Kenneth, Biason, Dorothy, McCoy, Madeline A, King, Lynette, Richards, Nicole, Harrington, Yi, Guo, Saira, Chaudhry, Xiaoning, Lu, Daohai, Yu
Publikováno v:
Open Forum Infectious Diseases
Background Multidrug-resistant Pseudomonas aeruginosa infections remain common in hospitals worldwide. We investigated the outcomes associated with the use of ceftolozane-tazobactam for the treatment of these infections. Methods Data were collected r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7b88cb0b979b2704dccc37f5138a405
https://pubmed.ncbi.nlm.nih.gov/30488041
https://pubmed.ncbi.nlm.nih.gov/30488041
Publikováno v:
Open Forum Infectious Diseases
Background Ceftolozane/tazobactam (TOL-TAZ) is a novel cephalosporin antibiotic combined with a known β-lactamase inhibitor. It has activity against some extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae and multidrug-resistant Pseu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d868e4cbb4cd28523542f4f5fcc29ce
https://doi.org/10.1093/ofid/ofy210.2035
https://doi.org/10.1093/ofid/ofy210.2035
Publikováno v:
Open Forum Infectious Diseases
Background Ceftolozane-tazobactam (TOL-TAZ) is a novel cephalosporin/β-lactamase inhibitor combination with potent activity against Pseudomonas aeruginosa, including MDRPA. TOL-TAZ use for MDRPA infections has not been well-studied. Methods We condu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd06966253d47c35888284ed497345e
http://europepmc.org/articles/PMC5632154
http://europepmc.org/articles/PMC5632154
Autor:
Esther Molnar
Publikováno v:
The Medicine Forum. 15
inTroDucTion Fibrosing mediastinitis (FM) is a rare disease of slowly progressive fibrosis that encases major mediastinal structures. Complications include obstruction of mediastinal vasculature, including main pulmonary arter ies, which may lead to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4492c71770255194b3d0a4394c1bc751
https://doi.org/10.29046/tmf.015.1.010
https://doi.org/10.29046/tmf.015.1.010